How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?
Gespeichert in:
| Veröffentlicht in: | Future medicinal chemistry 2016-07, Vol.8 (11), p.1153-1155 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1155 |
|---|---|
| container_issue | 11 |
| container_start_page | 1153 |
| container_title | Future medicinal chemistry |
| container_volume | 8 |
| creator | Ling, Qing-lan Murdoch, Emma Ruan, Ke-He |
| description | |
| doi_str_mv | 10.4155/fmc-2016-0084 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808379682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808379682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-add733ed94d0ea08eec7b74ada4c42cd36dcd0f6e4a82d1021f43a49876e7d013</originalsourceid><addsrcrecordid>eNp1kE1PxCAQhonRuGb16NVw9FIFSgs9mc36mWz0sJp4IwhTxWxBoWj893at7k0uw2SeeSd5EDqk5ITTqjptO1MwQuuCEMm30B4VVV3IhontzZ82E3SQ0isZXslkU1e7aMJEWYmayj30eB0-sdEefwLW1kZICfcvgE3wfQwfEJODhFOOMWRvnX_-meYEOLT4djm7OV9i57GHHIOFZ_AQde-CP9tHO61eJTj4rVP0cHlxP78uFndXN_PZojC8Yn0x3BRlCbbhloAmEsCIJ8G11dxwZmxZW2NJWwPXkllKGG15qXkjRQ3CElpO0fGY-xbDe4bUq84lA6uV9hByUlQSWYqmlmxAixE1MaQUoVVv0XU6filK1NqnGnyqtU-19jnwR7_R-akDu6H_7A1AMwJt7vOgzjjwBtTYDRvOOA__hH8DXjGFBg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808379682</pqid></control><display><type>article</type><title>How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?</title><source>MEDLINE</source><source>PubMed Central</source><creator>Ling, Qing-lan ; Murdoch, Emma ; Ruan, Ke-He</creator><creatorcontrib>Ling, Qing-lan ; Murdoch, Emma ; Ruan, Ke-He</creatorcontrib><identifier>ISSN: 1756-8919</identifier><identifier>EISSN: 1756-8927</identifier><identifier>DOI: 10.4155/fmc-2016-0084</identifier><identifier>PMID: 27357618</identifier><language>eng</language><publisher>England: Future Science Ltd</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Arachidonic Acid - metabolism ; COX-1-10aa-PGIS ; COX-2-10aa-mPGES-1 ; cyclooxygenase ; Cyclooxygenase 1 - chemistry ; Cyclooxygenase 1 - metabolism ; Cyclooxygenase 2 - chemistry ; Cyclooxygenase 2 - metabolism ; Dinoprostone - metabolism ; Epoprostenol - metabolism ; Humans ; hybrid enzyme ; neurodegeneration ; Neurodegenerative Diseases - drug therapy ; neuroinflammation ; nonsteroidal anti-inflammatory drugs ; NSAIDs ; PGE2 ; PGI2</subject><ispartof>Future medicinal chemistry, 2016-07, Vol.8 (11), p.1153-1155</ispartof><rights>Future Science Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-add733ed94d0ea08eec7b74ada4c42cd36dcd0f6e4a82d1021f43a49876e7d013</citedby><cites>FETCH-LOGICAL-c452t-add733ed94d0ea08eec7b74ada4c42cd36dcd0f6e4a82d1021f43a49876e7d013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27357618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ling, Qing-lan</creatorcontrib><creatorcontrib>Murdoch, Emma</creatorcontrib><creatorcontrib>Ruan, Ke-He</creatorcontrib><title>How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?</title><title>Future medicinal chemistry</title><addtitle>Future Med Chem</addtitle><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Arachidonic Acid - metabolism</subject><subject>COX-1-10aa-PGIS</subject><subject>COX-2-10aa-mPGES-1</subject><subject>cyclooxygenase</subject><subject>Cyclooxygenase 1 - chemistry</subject><subject>Cyclooxygenase 1 - metabolism</subject><subject>Cyclooxygenase 2 - chemistry</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Dinoprostone - metabolism</subject><subject>Epoprostenol - metabolism</subject><subject>Humans</subject><subject>hybrid enzyme</subject><subject>neurodegeneration</subject><subject>Neurodegenerative Diseases - drug therapy</subject><subject>neuroinflammation</subject><subject>nonsteroidal anti-inflammatory drugs</subject><subject>NSAIDs</subject><subject>PGE2</subject><subject>PGI2</subject><issn>1756-8919</issn><issn>1756-8927</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PxCAQhonRuGb16NVw9FIFSgs9mc36mWz0sJp4IwhTxWxBoWj893at7k0uw2SeeSd5EDqk5ITTqjptO1MwQuuCEMm30B4VVV3IhontzZ82E3SQ0isZXslkU1e7aMJEWYmayj30eB0-sdEefwLW1kZICfcvgE3wfQwfEJODhFOOMWRvnX_-meYEOLT4djm7OV9i57GHHIOFZ_AQde-CP9tHO61eJTj4rVP0cHlxP78uFndXN_PZojC8Yn0x3BRlCbbhloAmEsCIJ8G11dxwZmxZW2NJWwPXkllKGG15qXkjRQ3CElpO0fGY-xbDe4bUq84lA6uV9hByUlQSWYqmlmxAixE1MaQUoVVv0XU6filK1NqnGnyqtU-19jnwR7_R-akDu6H_7A1AMwJt7vOgzjjwBtTYDRvOOA__hH8DXjGFBg</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Ling, Qing-lan</creator><creator>Murdoch, Emma</creator><creator>Ruan, Ke-He</creator><general>Future Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160701</creationdate><title>How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?</title><author>Ling, Qing-lan ; Murdoch, Emma ; Ruan, Ke-He</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-add733ed94d0ea08eec7b74ada4c42cd36dcd0f6e4a82d1021f43a49876e7d013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Arachidonic Acid - metabolism</topic><topic>COX-1-10aa-PGIS</topic><topic>COX-2-10aa-mPGES-1</topic><topic>cyclooxygenase</topic><topic>Cyclooxygenase 1 - chemistry</topic><topic>Cyclooxygenase 1 - metabolism</topic><topic>Cyclooxygenase 2 - chemistry</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Dinoprostone - metabolism</topic><topic>Epoprostenol - metabolism</topic><topic>Humans</topic><topic>hybrid enzyme</topic><topic>neurodegeneration</topic><topic>Neurodegenerative Diseases - drug therapy</topic><topic>neuroinflammation</topic><topic>nonsteroidal anti-inflammatory drugs</topic><topic>NSAIDs</topic><topic>PGE2</topic><topic>PGI2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ling, Qing-lan</creatorcontrib><creatorcontrib>Murdoch, Emma</creatorcontrib><creatorcontrib>Ruan, Ke-He</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Future medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ling, Qing-lan</au><au>Murdoch, Emma</au><au>Ruan, Ke-He</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?</atitle><jtitle>Future medicinal chemistry</jtitle><addtitle>Future Med Chem</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>8</volume><issue>11</issue><spage>1153</spage><epage>1155</epage><pages>1153-1155</pages><issn>1756-8919</issn><eissn>1756-8927</eissn><cop>England</cop><pub>Future Science Ltd</pub><pmid>27357618</pmid><doi>10.4155/fmc-2016-0084</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1756-8919 |
| ispartof | Future medicinal chemistry, 2016-07, Vol.8 (11), p.1153-1155 |
| issn | 1756-8919 1756-8927 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1808379682 |
| source | MEDLINE; PubMed Central |
| subjects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Arachidonic Acid - metabolism COX-1-10aa-PGIS COX-2-10aa-mPGES-1 cyclooxygenase Cyclooxygenase 1 - chemistry Cyclooxygenase 1 - metabolism Cyclooxygenase 2 - chemistry Cyclooxygenase 2 - metabolism Dinoprostone - metabolism Epoprostenol - metabolism Humans hybrid enzyme neurodegeneration Neurodegenerative Diseases - drug therapy neuroinflammation nonsteroidal anti-inflammatory drugs NSAIDs PGE2 PGI2 |
| title | How can we address the controversies surrounding the use of NSAIDS in neurodegeneration? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A25%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20can%20we%20address%20the%20controversies%20surrounding%20the%20use%20of%20NSAIDS%20in%20neurodegeneration?&rft.jtitle=Future%20medicinal%20chemistry&rft.au=Ling,%20Qing-lan&rft.date=2016-07-01&rft.volume=8&rft.issue=11&rft.spage=1153&rft.epage=1155&rft.pages=1153-1155&rft.issn=1756-8919&rft.eissn=1756-8927&rft_id=info:doi/10.4155/fmc-2016-0084&rft_dat=%3Cproquest_cross%3E1808379682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808379682&rft_id=info:pmid/27357618&rfr_iscdi=true |